Departments and Services | For Patients | Research & Trials | Education | Find a Doctor


Search:
Division of Infectious Disease
 
    
Division of Infections Disease
 
Home
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Penn CFAR
Botswana-UPenn Partnership
Seminars
Faculty
Adjunct Faculty
Administrative Contacts
Outpatient Clinics
News

Faculty

faculty photo

Valerianna K. Amorosa, M.D.

Associate Professor of Clinical Medicine
Attending Physician, Hospital of the University of Pennsylvania
Attending Physician, Viral Hepatitis Clinic, Penn Presbyterian Medical Center
Chief, Infectious Diseases Section, Philadelphia Veteran's Administration Medical Center, University of Pennsylvania
Department: Medicine

Contact information
Philadelphia Veteran's Administration Medical Center,
Department of Medicine
Philadelphia, PA 19104
Office: 215-823-5800
Education:
B.A. (Molecular Biology Cum Laude)
Princeton University, 1993.
M.D.
Washington University in St. Louis, 1998.
Post-Graduate Training
Internship, Department of Medicine, University of Pennsylvania, 1998-1999.
Resident in Medicine, Department of Medicine, University of Pennsylvania, 1999-2001.
Postdoctoral Researcher, Hospital of the University of Pennsylvania, 2001-2001.
Infectious Diseases Fellowship, University of Pennsylvania, 2002-2004.
Certifications
ABIM, Infectious Diseases, 2004.
ABIM, Internal Medicine , 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical research in HIV, HCV coinfection

Description of Clinical Expertise

HIV, HIV/HCV coinfection

Selected Publications

Nagler Arielle R, Kim Brian S, Gormley Rachel H, Chandler Laura J, Han Jennifer H, Amorosa Valerianna K, Kovarik Carrie L: Verrucous nodule on the upper lip. Cutis 93(2): E15-7, Feb 2014.

Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG: Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV clinical trials 14(6): 274-83, Nov-Dec 2013.

Sulkowski MS, Kang M, Matining R, Wyles D, Johnson VA, Morse GD, Amorosa VK, Bhattacharya D, Coughlin K, Wong-Staal F, Glesby MJ: Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study. The Journal of infectious diseases Oct 2013.

Amorosa VK, Aibana O, Shire N, Dorey-Stein Z, Ferrara T, Gilmore J, Kostman J, Lo Re V: Willingness to Undergo a Repeat Liver Biopsy among HIV/Hepatitis C Virus-Coinfected and Hepatitis C Virus-Monoinfected Patients. Journal of Clinical Gastroenterology. (eds.). 47(5): 457-60, May-Jun 2013.

Gluckman, S. Amorosa, Valerianna K. Dismukes, W. Gordon: ABIM Update in Infectious Diseases. ABIM February 2013.

Lo Re V 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R : Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients AIDS Behav 17(1): 94-103, Jan 2013.

Lee YJ, Osinusi A, M Kang, T Umbleja, Amorosa VK, Kottilil S, Peters MG: Augmentation of Interferon signaling by Nitazoxanide in HIV HCV Coinfected Patients : Exploratory Analysis from the ACTG5269 trial. Conference on Retroviruses and Opportunistic Infections, March 2013, Atlanta GA. 2013.

Raphael BA, Dorey-Stein ZL, Lott J, Amorosa V, Lo Re V 3rd, Kovarik C : Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection J Am Acad Dermatol 67(5): 962-8, Nov 2012

Luetkemeyer A, Umbleja T, Amorosa V, Dayyeh B, Chung RT, Kang M, Bardin M, Haas DW, Tebas P, Peters M: Nitazoxanide (NTZ) may Mitigate the Unfavorable Association between IL28B Genotype and Hepatitis C Virus (HCV) Treatment Response to Pegylated Interferon-based therapy Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-143, 2012 Notes: Poster presentation.

Hafkin J, Osborn M, Kostman J, Chang KM, Amorosa V, Localio R, Mounzer K, Gross R, Lo Re V. : Incidence and Risk Factors for Incomplete HBV Suppression Among Tenofovir-Treated HIV/HBV-Coinfected Patients Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-173, 2012 Notes: Poster presentation.

back to top
Last updated: 04/16/2014
The Trustees of the University of Pennsylvania